In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries

Adrie, 1998, Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension, J. Appl. Physiol., 84, 435, 10.1152/jappl.1998.84.2.435

Archer, 1994, Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase, Proc. Natl. Acad. Sci. U.S.A., 91, 7583, 10.1073/pnas.91.16.7583

Archer, 1996, Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia, Circ. Res., 78, 431, 10.1161/01.RES.78.3.431

Bauer, 1995, Nitric oxide donors: biochemical pharmacology and therapeutics, Adv. Pharmacol., 34, 361, 10.1016/S1054-3589(08)61098-4

Brilli, 1997, Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension, J. Appl. Physiol., 83, 1968, 10.1152/jappl.1997.83.6.1968

De Meis, 1967, Relaxing effect of spermine and spermidine on intact and glycerol-treated muscle, Am. J. Physiol., 212, 92, 10.1152/ajplegacy.1967.212.1.92

Dinh-Xuan, 1991, Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease, New Engl. J. Med., 324, 1539, 10.1056/NEJM199105303242203

Diodati, 1993, Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: Hemodynamic effect in the rabbit, J. Cardiovasc. Pharmacol., 22, 287, 10.1097/00005344-199308000-00018

Feelisch, M., Stamler, J.S., 1996. Donors of nitrogen oxides. In: Feelisch, M., Stamler, J. (Eds.), Methods in nitric oxide research. Wiley, Chichester, pp. 71–115.

Garthwaite, 1995, Potent and selective inhibition of nitric oxide sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Mol. Pharmacol., 48, 184

Hampl, 1996, Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension, Cardiovasc. Res., 31, 55, 10.1016/0008-6363(95)00172-7

Henry, 1989, Nitroglycerine-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade, J. Pharmacol. Exp. Ther., 248, 762

Homer, 1997, A comparison of two NONOates (novel nitric oxide donors) on rat pulmonary artery preparations, Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol., 4, 65

Hrabie, 1993, New nitric oxide-releasing zwitterions derived from polyamines, J. Org. Chem., 58, 1472, 10.1021/jo00058a030

Keefer, 1996, `NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms, Methods Enzymol., 268, 281, 10.1016/S0076-6879(96)68030-6

Kelm, M., Yoshida, K., 1996. Metabolic fate of nitric oxide and related N-oxides. In: Feelisch, M., Stamler, J. (Eds.), Methods in nitric oxide research. Wiley, Chichester, pp. 47–58.

Kukovetz, 1989, Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries, J. Cardiovasc. Pharmacol., 14, S40, 10.1097/00005344-198914110-00008

Longhi, 1962, Reactions of nitrogen(II) oxide with miscellaneous Lewis bases, Inorg. Chem., 1, 768, 10.1021/ic50004a011

Maragos, 1991, Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects, J. Med. Chem., 34, 3242, 10.1021/jm00115a013

Morley, 1993, Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators, J. Cardiovasc. Pharmacol., 21, 670, 10.1097/00005344-199304000-00023

Ragsdale, 1965, Decomposition of the adducts of diethylamine and isopropylamine with nitrogen(II) oxide, Inorg. Chem., 4, 420, 10.1021/ic50025a038

Schrammel, 1996, Characterisation of 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase, Mol. Pharmacol., 50, 1

Van de Voorde, 1989, Relaxations to endothelium-derived relaxing factor and the metabolite of molsidomine (SIN-1), in the aorta and the hindquarters of the rat, J. Cardiovasc. Pharmacol., 14, S55, 10.1097/00005344-198914110-00010

Vanderford, 1994, Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs, J. Cardiovasc. Pharmacol., 23, 113, 10.1097/00005344-199401000-00016

Wanstall, 1995, Evidence that nitric oxide from the endothelium attenuates inherent tone in isolated pulmonary arteries from rats with hypoxic pulmonary hypertension, Br. J. Pharmacol., 114, 109, 10.1111/j.1476-5381.1995.tb14913.x

Wanstall, 1997, Evaluation of bosentan, pinacidil and nitroprusside on human pulmonary arteries: comparison with rat pulmonary arteries, Fundam. Clin. Pharmacol., 11, 584, 10.1111/j.1472-8206.1997.tb00864.x

Wanstall, 1997, The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats, Br. J. Pharmacol., 121, 280, 10.1038/sj.bjp.0701105